CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 1,388 enrolled
Drug / intervention
Electromagnetic Navigation Bronchoscopyprocedure
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02410837
NCT02410837N/ACompleted

NAVIGATE: Clinical Evaluation of superDimension™ Navigation System for Electromagnetic Navigation Bronchoscopy™

Medtronic - MITG·observational·Posted Apr 8, 2015·Updated May 10, 2021

In Brief

An observational study evaluating Electromagnetic Navigation Bronchoscopy for Lung Lesion(s) Requiring Evaluation. Completed, enrolled 1,388 participants across 37 sites in 7 countries.

Detailed Summary

The purpose of this study is to evaluate outcomes following electromagnetic navigation bronchoscopy™ (ENB™) procedures using the superDimension™ navigation system.

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
CountriesAustria, Denmark, France, Italy, Spain, United Kingdom, United States
Collaborators--

Timeline

N/ACompletedFinished
201520162017201820192020202120222023202420252026
First PostedApr 8, 2015
Enrollment StartApr 16, 2015
Primary CompletionNov 1, 2019
TodayJul 2, 2026
Enrollment to primary: 4.5 yearsPosted 11.2 years ago

Interventions

Electromagnetic Navigation Bronchoscopyprocedure